FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...
Please provide your email address to receive an email when new articles are posted on . NEW YORK — In this Healio Video Perspective from OSN New York, Karolinne M. Rocha, MD, PhD, discusses tolerance ...
Additional research being presented also reports positive visual and refractive outcomes associated with TECNIS Eyhance, and suggests that TECNIS Symfony OptiBlue provides mild glaucoma patients the ...
Please provide your email address to receive an email when new articles are posted on . A two-step femtosecond laser-guided procedure may be a good option for high astigmatism. Patients with ...
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity
Alcon innovations featured in approximately 180 abstracts across cataract, glaucoma, refractive, visualization and ocular health1 New data demonstrates comparable range of vision and intermediate ...
TECNIS Odyssey IOL offers higher tolerance to residual refractive errors, enabling surgeons to deliver consistent and reliable patient outcomes. 5¶ Experience the ...
Johnson & Johnson (J&J), a provider of eye health solutions, has expanded the availability of its TECNIS Odyssey intraocular lens (IOL) in the US. Built on the TECNIS platform, TECNIS Odyssey IOL ...
"TECNIS Odyssey IOL is the fastest growing PC-IOL in the United States, ^ and we are excited to be making it available to more patients around the world. It addresses a significant unmet need for ...
Johnson & Johnson (J&J) has introduced the TECNIS Odyssey IOL in the Middle East, Canada, and Europe, expanding its range of presbyopia-correcting intraocular lenses (PC-IOLs). This new lens is ...
Patient Reported Outcomes and Visual Acuity after Bilateral Implantation of a Next Generation Presbyopia Correcting Intraocular Lens; Brunson, OD, Hacopian, MD. (Abstract #107160) Interim results from ...
J&J to be included in 22 abstracts evaluating research, clinical, and patient reported outcomes JACKSONVILLE, Fla. , April 25, 2025 /PRNewswire/ -- Johnson & Johnson, a global leader in eye health, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback